UBI Multivalent HIV-1 Peptide Immunogen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UBI Multivalent HIV-1 Peptide Immunogen, covering 2008-09-09 to 2008-09-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects [Phase 1]